We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Panel Votes to Approve OTC Status For Weight Loss Drug
FDA Panel Votes to Approve OTC Status For Weight Loss Drug
January 27, 2006
GlaxoSmithKline (GSK) moved one step closer to marketing it anti-obesity drug Xenical without a prescription after an FDA advisory panel overwhelmingly recommended the agency approve the company’s application to sell the drug OTC.